A Hugh Mostafid
Overview
Explore the profile of A Hugh Mostafid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
2179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Int Urol Nephrol
. 2023 Nov;
56(4):1323-1333.
PMID: 37980689
Purpose: A re-transurethral resection of the bladder (re-TURB) is a well-established approach in managing non-muscle invasive bladder cancer (NMIBC) for various reasons: repeat-TURB is recommended for a macroscopically incomplete initial...
2.
Beijert I, Cheng L, Liedberg F, Plass K, Williamson S, Gontero P, et al.
Eur Urol Open Sci
. 2023 Jun;
52:154-165.
PMID: 37284047
Background: Grade of non-muscle-invasive bladder cancer (NMIBC) is an important prognostic factor for progression. Currently, two World Health Organization (WHO) classification systems (WHO1973, categories: grade 1-3, and WHO2004 categories: papillary...
3.
Roupret M, Seisen T, Birtle A, Capoun O, Comperat E, Dominguez-Escrig J, et al.
Eur Urol
. 2023 Mar;
84(1):49-64.
PMID: 36967359
Context: The European Association of Urology (EAU) guidelines panel on upper urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in evidence-based management of UTUC. Objective: To...
4.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Oncol
. 2023 Jan;
6(2):214-221.
PMID: 36670042
Background: Ta grade 3 (G3) non-muscle-invasive bladder cancer (NMIBC) is a relatively rare diagnosis with an ambiguous character owing to the presence of an aggressive G3 component together with the...
5.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Focus
. 2022 May;
8(6):1627-1634.
PMID: 35577750
Background: The pathological existence and clinical consequence of stage T1 grade 1 (T1G1) bladder cancer are the subject of debate. Even though the diagnosis of T1G1 is controversial, several reports...
6.
Rai B, Dominguez Escrig J, Vale L, Kuusk T, Capoun O, Soukup V, et al.
Eur Urol
. 2022 Apr;
82(2):182-192.
PMID: 35393159
Context: The current impact of haematuria investigations on health care organisations is significant. There is currently no consensus on how to investigate patients with haematuria. Objective: To evaluate the incidence...
7.
Babjuk M, Burger M, Capoun O, Cohen D, Comperat E, Dominguez Escrig J, et al.
Eur Urol
. 2021 Sep;
81(1):75-94.
PMID: 34511303
Context: The European Association of Urology (EAU) has released an updated version of the guidelines on non-muscle-invasive bladder cancer (NMIBC). Objective: To present the 2021 EAU guidelines on NMIBC. Evidence...
8.
van Rhijn B, Hentschel A, Brundl J, Comperat E, Hernandez V, Capoun O, et al.
Eur Urol Oncol
. 2021 Jan;
4(2):182-191.
PMID: 33423944
Background: In the current European Association of Urology (EAU) non-muscle-invasive bladder cancer (NMIBC) guideline, two classification systems for grade are advocated: WHO1973 and WHO2004/2016. Objective: To compare the prognostic value...
9.
Roupret M, Babjuk M, Burger M, Capoun O, Cohen D, Comperat E, et al.
Eur Urol
. 2020 Jun;
79(1):62-79.
PMID: 32593530
Context: The European Association of Urology (EAU) Guidelines Panel on Upper Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid clinicians in the current evidence-based management of UTUC...
10.
Mostafid A, Porta N, Cresswell J, Griffiths T, Kelly J, Penegar S, et al.
BJU Int
. 2020 Mar;
125(6):817-826.
PMID: 32124514
Objectives: To evaluate the activity of intravesical mitomycin-C (MMC) to ablate recurrent low-risk non-muscle-invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment...